Gastric xenon trapping mimicking COPD: Recognition using an effervescent agent
dc.contributor.author | Wahl, Richard L. | en_US |
dc.date.accessioned | 2006-09-11T18:14:52Z | |
dc.date.available | 2006-09-11T18:14:52Z | |
dc.date.issued | 1986-07 | en_US |
dc.identifier.citation | Wahl, Richard L.; (1986). "Gastric xenon trapping mimicking COPD: Recognition using an effervescent agent." European Journal of Nuclear Medicine 12(3): 155-157. <http://hdl.handle.net/2027.42/46824> | en_US |
dc.identifier.issn | 0340-6997 | en_US |
dc.identifier.issn | 1619-7089 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46824 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3758105&dopt=citation | en_US |
dc.description.abstract | Trapping of xenon 133 in the stomach due to gas swallowing can mimic xenon 133 retention in the left lower lobe due to obstructive lung disease on pulmonary ventilation/perfusion studies. In such cases, ingestion of sodium citrate-bicarbonate-simethicone crystals, which from CO 2 gas on contact with water, can distend the xenoncontaining stomach and allow clear delineation of its gastric location. This approach is useful in selected cases and may help avoid false-positive diagnoses of obstructive airways disease. | en_US |
dc.format.extent | 379234 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Imaging / Radiology | en_US |
dc.subject.other | Nuclear Medicine | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | V/Q Scanning | en_US |
dc.subject.other | Pulmonary Embolism Detection | en_US |
dc.subject.other | Chronic Obstructive Lung Disease | en_US |
dc.title | Gastric xenon trapping mimicking COPD: Recognition using an effervescent agent | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Radiology | en_US |
dc.subject.hlbsecondlevel | Physics | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Nuclear Medicine, University of Michigan Medical Center, 1500 East Medical Center Drive, 48109-0028, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 3758105 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46824/1/259_2004_Article_BF00276710.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00276710 | en_US |
dc.identifier.source | European Journal of Nuclear Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.